City Therapeutics (NASDAQ:CTY) Major Shareholder Purchases 170,000 Shares of Stock

City Therapeutics, Inc. (NASDAQ:CTY - Get Free Report) major shareholder Arch Venture Partners Xii, Llc bought 170,000 shares of the company's stock in a transaction that occurred on Monday, October 19th. The stock was purchased at an average cost of $18.00 per share, for a total transaction of $3,060,000.00. Following the transaction, the insider owned 13,692,507 shares in the company, valued at $246,465,126. The trade was a 1.26% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

City Therapeutics Trading Down 4.2%

NASDAQ CTY opened at $21.46 on Tuesday. City Therapeutics, Inc. has a 52 week low of $20.50 and a 52 week high of $23.88.

City Therapeutics Company Profile

(Get Free Report)

Recommended Stories

• Five stocks we like better than City Therapeutics
• Tesla's Roadster Reveal Hints at 2 Much Bigger Moves
• The AI Sell-Off Continues—These 3 Stocks Keep Raising Guidance Anyway
• Mr. Wonderful’s Test for AI Data Center Stocks: Power, Permits, and Tenants
• Alcoa Beat Earnings, But Can It Escape the Aluminum Bears?

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].